Journal ArticleDOI
Arrest of Hyperparathyroid Bone Disease with Dihydrotachysterol in Patients Undergoing Chronic Hemodialysis
TLDR
There was marked improvement in patients with active bone disease who were on a chronic dialysis program who were treated with dihydrotachysterol, 0.25 to 0.375 mg/day, probably due in part to the drug’s ability to relax the immune system.Abstract:
Six patients with active bone disease who were on a chronic dialysis program were treated with dihydrotachysterol, 0.25 to 0.375 mg/day. There was marked improvement, probably due in part ...read more
Citations
More filters
Journal ArticleDOI
The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone.
TL;DR: A large number of studies have shown that high levels of vitamin D in the blood stream is beneficial for the physical and mental well-being of mice and young people.
Journal ArticleDOI
Vitamin D: current concepts.
Journal ArticleDOI
Vitamin D in solution: conformations of vitamin D3, 1alpha,25-dihydroxyvitamin D3, and dihydrotachysterol3.
TL;DR: In this article, the A and seco B rings of vitamin D(3), 1(alpha), 25-dihydroxyvitamin D (3), and dihydrotachysterol(3) have been established by high resolution, 300-megahertz proton magnetic resonance spectroscopy.
References
More filters
Journal ArticleDOI
Modifications of a specific assay for hydroxyproline in urine
TL;DR: Several modifications of a specific chemical assay for hydroxyproline in urine are presented which make the procedure more rapid without reducing its specificity or accuracy.
Journal ArticleDOI
25-Hydroxycholecalciferol. A biologically active metabolite of vitamin D3
Journal ArticleDOI
Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effects of dihydrotachysterol (A. T. 10) and iron.
S. H. Liu,H. I. Chu +1 more
Journal ArticleDOI
Caclium, phosphorus, and bone in renal disease and transplantation.
TL;DR: In patients receiving long-term hemodialysis, if hyperphosphatemia and hypocalcemia persist, PTH levels may remain high and osteitis fibrosa may progress, and severe hypercalcemia must be guarded against.
Journal ArticleDOI
The metabolic fate of vitamin D3-3H in chronic renal failure
TL;DR: The experiments support the conclusion that the resistance to therapeutic doses of vitamin D often seen in patients with chronic renal failure and renal osteodystrophy results from an acquired defect in the metabolism and excretion of Vitamin D.
Related Papers (5)
Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite
D. R. Fraser,E. Kodicek +1 more
Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effects of dihydrotachysterol (A. T. 10) and iron.
S. H. Liu,H. I. Chu +1 more
Metabolic studies of renal osteodystrophy. I. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia and hyperparathyroidism complicating chronic uremia and in the osteomalacia of the adult Fanconi syndrome.
Stanbury Sw,Lumb Ga +1 more